Metabolic syndrome can adversely affect surgical outcomes. This study evaluated the postoperative outcomes of patients with metabolic syndrome after total shoulder arthroplasty (TSA). A retrospective cohort study of 4751 patients undergoing TSA was conducted with use of the American College of Surgeons National Surgical Quality Improvement Program database from 2005 to 2013. Metabolic syndrome was defined as hypertension, diabetes, and body mass index of 30.0 kg/m 2 or greater. Multivariable logistic regression analysis was performed for the outcomes of any postoperative complications and extended length of stay. Patients classified as obese III had a significantly increased risk of extended length of stay (P=.011) compared with control subjects who were of normal weight. In the multivariable adjusted models, compared with nonobese patients, those classified as obese I and obese II had a significantly decreased risk of postoperative complications (odds ratio, 0.84, P=.020, and odds ratio, 0.82, P=.045, respectively), whereas those classified as obese I were less likely to have extended length of stay (odds ratio, 0.79, P=.004). Metabolic syndrome was not a significant predictor of postoperative complications or extended length of stay. Morbidly obese patients undergoing TSA have an increased risk of postoperative complications and extended length of stay. Those classified as obese I and obese II may have a decreased risk of postoperative complications and shorter length of stay. Despite the hypothesized negative effect of metabolic syndrome on outcomes, the overall effect of metabolic syndrome was insignificant. These results are consistent with previous studies on obesity in patients undergoing TSA and may explain why recent studies have not shown differences in the rate of complications after TSA in obese patients with a body mass index of 30 to 40 mg/kg abstract ditional morbidity associated with TSA as a result of obesity and metabolic syndrome is an important area of investigation. 7, 8 Patients with metabolic syndrome pose additional challenges with exposure, increased operative time, and wound complications. 9, 10 There is evidence in the orthopedic literature that metabolic syndrome may synergistically worsen outcomes compared with obesity alone, most notably in studies of hip and knee arthroplasty. 11, 12 To date, studies of TSA have only examined the effect of obesity on complication rates, without consideration of concomitant hypertension and diabetes. Studies evaluating complication rates after TSA in obese patients have yielded mixed results. Some authors described improved range of motion in obese patients compared with patients of normal weight, 13, 14 whereas others noted minimal differences compared with nonobese patients. 15 A large database study by Griffin et al 16 found no difference overall in moderately obese patients and only slight increases in pulmonary complications and length of stay in morbidly obese patients. Overall, most studies showed increased complication rates in morbidly obese patients.
To date, no study has investigated the effect of metabolic syndrome on extended length of stay and short-term perioperative complications in patients undergoing TSA. The authors hypothesized that patients with metabolic syndrome will have increased postoperative complications compared with unaffected patients. In addition, the authors hypothesized that morbidly obese patients will have higher complication rates compared with mildly and moderately obese patients, irrespective of metabolic syndrome.
Materials and Methods
A retrospective cohort study of patients undergoing TSA was conducted with data from the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) from 2005 to 2013.
The database was queried for cases of TSA with Current Procedural Terminology (CPT) code 23472.
The NSQIP 17 is a prospectively collected, risk-adjusted, multicenter outcomes program. The program tabulates demographic and comorbidity data, anthropometric values, preoperative laboratory results, and perioperative data. It also collects postoperative outcomes and adverse events up to the 30th postoperative day, regardless of when the patient was discharged.
In this study, patients were categorized by body mass index according to the World Health Organization classification, as follows: nonobese (body mass index, 18. 18 Underweight patients with body mass index of less than 18.5 were excluded because the focus of the study was to compare obese patients with patients of normal weight and overweight patients. Metabolic syndrome was defined as hypertension requiring medication, diabetes, and body mass index of 30.0 kg/m 2 or greater. This is an established definition that has been used in similar studies. 19 Demographic and comorbidity characteristics were compared across obesity classes with Pearson's chi-square test. Individual comorbidities were categorized as cardiovascular, pulmonary, renal, cerebrovascular, or other. Rates of postoperative complications were compared across obesity classes and in patients with and without diabetes, hypertension, and metabolic syndrome. Extended length of stay was defined as a hospital stay longer than 2 days, corresponding to the 70th percentile in the current cohort. Wound complications included superficial, deep, organ and space surgical site infection, and wound dehiscence. Urinary complications were defined as progressive renal insufficiency, acute renal failure, and urinary tract infections. Respiratory complications included pneumonia, unplanned intubation, and failure to wean off the ventilator. Central nervous system complications included cerebrovascular accident or stroke with neurologic deficit, coma for more than 24 hours, and peripheral nerve injury. Cardiac complications included cardiac arrest requiring cardiopulmonary resuscitation and myocardial infarction. Operative time and absolute length of stay were also compared across obesity classes with unadjusted univariate analysis of variance.
The Bonferroni correction was applied to the multiple comparisons to determine the level of significance within each comparison, which was set at P<.0039. In patients with 1 or more complications as well as extended length of stay, pairwise Pearson's chi-square test was performed between the nonobese group and each of the obese I, obese II, and obese III groups.
Multivariable adjusted logistic regression was performed for the outcomes of 1 or more complications overall and extended length of stay because these were the most consistently statistically significant outcomes in the bivariate unadjusted analyses. All logistic regressions were adjusted for age, sex, diabetes, hypertension, any cardiac comorbidity (not including hypertension), any pulmonary comorbidity, history of cerebrovascular events, and history of steroid use. Regressions for the obesity classes were performed relative to the nonobese class. In the regressions for metabolic syndrome, diabetes, and hypertension, body mass index was adjusted for as a continuous variable. Odds ratio (OR) with 95% confidence interval (CI) was calculated. P<.05, or if the 95% CI did not include 1.0, was considered statistically significant. All statistical tests were 2-tailed. Analysis was performed with SPSS version 22 software (IBM Corp, Armonk, New York).
results
The study population included 4751 patients from the NSQIP database who underwent TSA. This group included 2457 nonobese patients (51.7%), 1235 patients classified as obese I (26.0%), 619 patients classified as obese II (13.0%), and 440 patients classified as obese III (9.3%). Analysis of race showed that more than 80% of patients were identified as white and only 5% of patients were identified as black. More than 95% of patients underwent general anesthesia.
Higher obesity class correlated with female sex (P<.001), black race (P<.001), and younger age (P<.001). As body mass index increased, patients had increased risk of American Society of Anesthesiologists class of 3 or greater (P=.023). Small but significant differences also were seen in preoperative functional status and type of anesthesia used ( Table 1) .
Bivariate analysis of postoperative complications was performed across obesity classes as well as between patients with and without metabolic syndrome. Across obesity classes, extended length of stay and operative time were significantly different by analysis of variance (P<.001). For 1 or more complications across obesity classes, the differences approached statistical significance (P=.007) ( Table 2) .
Patients with metabolic syndrome had increased rates of extended length of stay and an increased rate of 1 or more complications (P<.001) ( Table 3) .
Individual class comparisons were performed between nonobese patients and each obesity class (Figure 1) . Compared with nonobese patients, those classified as obese I had a decreased risk of having 1 or more complications as well as a lower rate of extended length of stay (P=.018 and P=.004, respectively). No significant difference in outcomes was found between patients classified as obese II and nonobese patients (P=.35 and P=.82, respectively). For patients classified as obese III, an increased risk of complications and a significantly increased risk of extended length of stay was found compared with the nonobese cohort (P=.07 and P=.001, respectively).
In the multivariable logistic regression models ( (Figure 2) .
discussion
Obesity and metabolic syndrome are increasingly prevalent comorbidities in patients undergoing orthopedic surgery, with potentially substantial adverse effects on postoperative outcomes. Studies from the hip and knee arthroplasty literature have shown that these patients may be at increased risk for serious postoperative complications. 11, 12 Among studies in patients undergoing TSA, the effect of obesity on postoperative outcomes has been mixed. [13] [14] [15] [16] 20 To the authors' knowledge, metabolic syndrome in TSA has not been studied previously.
The main hypothesis of this study, which used a large multicenter prospectively collected surgical outcomes database, was that patients with metabolic syndrome would have significantly increased postoperative complications after TSA. This was found by bivariate analysis; however, this hypothesis was not supported by the results of this study. Patients with metabolic syndrome had no significant difference in short-term postoperative complications or length of stay, after statistical adjustment. Similarly, although unadjusted analysis showed that patients classified as obese III, or morbidly obese patients, were more likely to have postoperative complications and extended length of stay, this effect was not statistically significant in the multivariable models.
The current literature has largely shown that morbid obesity is associated with an increased risk of complications and extended length of stay after TSA. This finding was consistent with the bivariate unadjusted findings in the current study, which showed that postoperative complications and extended length of stay in patients classified as obese III were statistically significant with the Bonferroni correction compared with nonobese patients. After multivariable adjustment for demographics and comorbidities, including the other components of metabolic syndrome (hypertension and diabetes), these variables were not statistically significant.
Two other large database studies reported complications associated with obesity after TSA. Griffin et al 16 used the Nationwide Inpatient Sample (NIS) database to investigate the effects of obesity on surgical outcomes. These authors found that morbidly obese patients had increased length of stay (2.84 vs 2.56 days), higher hospital charges, and more pulmonary complications (OR, 1.2 vs 0.7) compared with nonobese control subjects. These outcomes were statistically significant, but their clinical significance, based on the small absolute differences, warrants further investigation. The other postoperative outcomes in their study were not statistically associated with obesity, and these findings are largely consistent with the results of the current study. De- spite the larger sample size in the study by Griffin et al 16 (31,294), however, a major limitation of their study was their use of the NIS database, which has been shown to be an unacceptable data source for obesity-related research on clinical outcomes. 21, 22 Although obesity data in the NSQIP database are determined from actual prospectively collected height and weight values, obesity designations in the NIS database are based on International Classification of Diseases, Ninth Revision (ICD-9), coding, which has been shown to dramatically underestimate the prevalence of obesity. 23 Obesity is coded only if a hospital coder discerns it from retrospective review of medical records for billing purposes and determines that it is an important code for the patient's hospital stay. Griffin et al 16 found a prevalence of obesity of just 7.5%, with 1.8% of patients being morbidly obese, findings that were significantly lower than those reported in the current study (48.3% and 9.3%, respectively).
In another study, Waterman et al 24 used the NSQIP database to evaluate morbidity and mortality after TSA and found no difference in complications and length of stay for obese patients compared with a nonobese population. Their study did not focus specifically on obesity, however, and the study cohort was not stratified into additional obesity classes. Nonetheless, these findings are consistent with the results of the current study. In a study of functional outcomes, Linberg et al 13 found improved pain and range of motion in 45 morbidly obese patients who underwent TSA, but reported no difference in complications compared with a cohort of patients who were of normal weight.
For lower levels of obesity, the current study found a lower risk of complications after TSA in patients classified as obese I. In these patients, unadjusted and adjusted rates of postoperative complications and length of stay were lower compared with nonobese patients (P<.05). These findings were similar to those of Gupta et al, 25 who reported lower complication rates after reverse TSA in patients with body mass index of 25 to 35 kg/m 2 Griffin et al 16 showed lower rates of cardiac complications, genitourinary complications, and psychosis in moderately obese patients, although this study did not perform multivariable analysis for these findings. Several other studies showed no difference in complication rates for patients with body mass index of 30 to 40 mg/kg 2 compared with nonobese patients. 15, 24 An important feature of the current study was the stratification of obese patients into additional subgroups established by the World Health Organization: obese I, obese II, and obese III. Based on the results of this study, those classified as obese I and obese II potentially should be considered separately from those classified as obese III because these patients had unexpectedly decreased rates of postoperative adverse events compared with nonobese patients. A potential explanation for this finding is that, in an era in which more than 30% of the US population is obese, 26 nonobese patients undergoing TSA may have worse nutritional status than those classified as obese I and perhaps obese II. 23 Additional studies are needed to better understand the potential effect of nutritional status on outcomes after TSA.
The second focus of the current study was on the effect of metabolic syndrome, which is the confluence of obesity, hypertension, and diabetes that has become increasingly prevalent in parallel with obesity. After adjusted regression analysis, metabolic syndrome did not significantly affect length of stay or the incidence of postoperative complications compared with patients without metabolic syndrome. In comparison, hypertension and diabetes alone each conferred a significantly increased risk of postoperative complications and increased length of stay, and it was hypothesized that metabolic syndrome would confer a synergistic increase in postoperative complications. Given the lower complication rates associated with mild and moderate obesity, however, the overall effect of metabolic syndrome was decreased relative to hypertension and diabetes (Figure 2) .
To the authors' knowledge, this is the first study examining the effect of metabolic syndrome in patients undergoing TSA. In the hip and knee arthroplasty literature, studies by Gage et al 12 and Gonzalez Della Valle et al 11 found significantly longer length of stay and increased complication rates in patients with metabolic syndrome. However, neither study performed multivariable adjustment to account for confounding factors. Nevertheless, the finding of no adverse effect in this study may indicate that different thresholds of obesity should be used for patients undergoing TSA compared with those undergoing arthroplasty of the lower extremity, given the significant differences in anatomy, surgical approach, and function. In terms of preoperative risk stratification and counseling, surgeons who perform TSA should be aware of the increased risks associated with hypertension, diabetes, and obese III classification as a modified metabolic syndrome in patients undergoing TSA.
There were several limitations to this study. First, the NSQIP database does not capture complications beyond the 30th postoperative day. Further, the NSQIP database does not include orthopedicspecific outcomes, such as functional scores and range of motion. Finally, because patients undergoing TSA were identified from the NSQIP database with CPT codes rather than ICD-9 codes, it was impossible to differentiate those undergoing reverse TSA from those receiving anatomic TSA implants. As mentioned previously, however, the use of ICD-9 coding in studies such as those analyzing the NIS database may grossly underestimate the prevalence of obesity and other medical comorbidities. Therefore, the lack of differentiation between patients undergoing reverse TSA and those with anatomic TSA was an unfortunate but necessary decision that was made during study design because the goal was to analyze accurate demographic, anthropometric, and comorbidity data. 21, 22 Further, recent data have shown little disparity in short-term postoperative outcomes between patients undergoing reverse TSA and those undergoing anatomic TSA. 27, 28 Finally, a potential confounding factor in the analysis of length of stay was that elderly patients with Medicare may be required to stay in the hospital for at least 3 nights to be eligible for discharge to a rehabilitation or skilled nursing facility. Although the current multivariable analysis was adjusted for age, unfortunately, insurance information is not available in the NSQIP database.
conclusion
Obesity and metabolic syndrome are important risk factors to consider in patients undergoing TSA. In this study of patients undergoing TSA from the multicenter NSQIP database, mildly obese patients had decreased risk of short-term postoperative complications (OR, 0.84) and extended length of stay (OR, 0.79) compared with nonobese patients. The other components of metabolic syndrome, hypertension and diabetes, were associated with increased risk of complications and extended length of stay. However, the overall effect of metabolic syndrome in patients with body mass index of 30 kg/m 2 or greater did not reach statistical significance. For risk stratification and preoperative counseling of patients, surgeons who perform TSA should consider classification of patients as obese I, obese II, and obese III along with consideration of medical comorbidities, including hypertension and diabetes.
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